Lataa...
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Dabigatran is an oral anticoagulant that is increasingly used for atrial fibrillation (AF). Presently, many authorities state that routine laboratory coagulation monitoring is not required. However, data have recently been published demonstrating that higher trough plasma dabigatran concentrations a...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BlackWell Publishing Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243910/ https://ncbi.nlm.nih.gov/pubmed/24592851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12364 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|